SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 4:12 PM ETAbout this dataData status
$27.44▼-0.18 (-0.67%)
After Hours:$27.44+0.00 (+0.00%)· 4:12 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Current Ratio

12.88×

TTM · Retrieved:

PBLS logo

PBLS Current Ratio

Current (TTM)12.88×
PBLS Current Ratio (2.84× → 12.88×)
High-resolution chart · PNG

What is current ratio?

The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.

Compare current ratio

Values are from the market snapshot of .

PBLS current ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Parabilis Medicines, Inc. Current Ratio — Annual fiscal periods
Period endingCurrent RatioChange
0.5169×−81.83%
2.8449×—

Frequently asked questions: PBLS current ratio

What is Parabilis Medicines, Inc. (PBLS)'s current current ratio?

Parabilis Medicines, Inc. (PBLS)'s latest reported current ratio (TTM) is 12.88× as of Nov 20, 2026. The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.

How much historical current ratio data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s current ratio, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's current ratio to peers or set an alert?

You can compare PBLS's current ratio directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.